Adrenal abnormalities in idiopathic hirsutism.
The possibility that abnormal adrenal androgen production may be present in patients with idiopathic hirsutism was examined. Plasma testosterone, dihydrotestosterone and androstenedione levels were elevated in hirsute patients. In response to exogenous alpha 1-24 ACTH the increments in plasma androstenedione, dehydroepiandrosterone (DHA) and cortisol were significantly greater in hirsute patients than in normal subjects. The testosterone response was exaggerated following endogenous stimulation induced by metyrapone. Treatment with dexamethasone, 0.5 mg each night for 3 months, corrected both the androgen excess and the exaggerated androgen responses but not the excessive cortisol response to stimulation. These observations indicate adrenal abnormalities in idiopathic hirsutism. The dissociation of cortisol and adrenal androgen responsiveness following dexamethasone suggests that the abnormalities observed may be due to excessive adrenal androgen production stimulated by a dexamethasone-suppressible factor other than ACTH. Excess adrenal androgen production may be the primary disorder leading to the development of idiopathic hirsutism.
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000304:Adrenal Cortex Function Tests; D000311:Adrenal Glands / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone; D000728:Androgens / Q000097:blood; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood; D008797:Metyrapone; D012738:Sex Hormone-Binding Globulin / Q000032:analysis
D015065:17-Hydroxycorticosteroids; D000728:Androgens; D006908:Hydroxyprogesterones; D012738:Sex Hormone-Binding Globulin; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone